skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: Nome da Publicação: Annals Of Oncology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Association between CD8+ T-cell infiltration and breast cancer survival in 12 439 patients
Association between CD8+ T-cell infiltration and breast cancer survival in 12 439 patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

Association between CD8+ T-cell infiltration and breast cancer survival in 12 439 patients

Ali, H.R. ; Provenzano, E. ; Dawson, S.-J. ; Blows, F.M. ; Liu, B. ; Shah, M. ; Earl, H.M. ; Poole, C.J. ; Hiller, L. ; Dunn, J.A. ; Bowden, S.J. ; Twelves, C. ; Bartlett, J.M.S. ; Mahmoud, S.M.A. ; Rakha, E. ; Ellis, I.O. ; Liu, S. ; Gao, D. ; Nielsen, T.O. ; Pharoah, P.D.P. ; Caldas, C.

Annals of oncology, 2014-08, Vol.25 (8), p.1536-1543 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
2
Outcome and molecular landscape of patients with PIK3CA-mutated metastatic breast cancer
Outcome and molecular landscape of patients with PIK3CA-mutated metastatic breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Outcome and molecular landscape of patients with PIK3CA-mutated metastatic breast cancer

Mosele, F. ; Stefanovska, B. ; Lusque, A. ; Tran Dien, A. ; Garberis, I. ; Droin, N. ; Le Tourneau, C. ; Sablin, M.-P. ; Lacroix, L. ; Enrico, D. ; Miran, I. ; Jovelet, C. ; Bièche, I. ; Soria, J.-C. ; Bertucci, F. ; Bonnefoi, H. ; Campone, M. ; Dalenc, F. ; Bachelot, T. ; Jacquet, A. ; Jimenez, M. ; André, F.

Annals of oncology, 2020-03, Vol.31 (3), p.377-386 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
3
Neoadjuvant paclitaxel/olaparib in comparison to paclitaxel/carboplatinum in patients with HER2-negative breast cancer and homologous recombination deficiency (GeparOLA study)
Neoadjuvant paclitaxel/olaparib in comparison to paclitaxel/carboplatinum in patients with HER2-negative breast cancer and homologous recombination deficiency (GeparOLA study)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Neoadjuvant paclitaxel/olaparib in comparison to paclitaxel/carboplatinum in patients with HER2-negative breast cancer and homologous recombination deficiency (GeparOLA study)

Fasching, P.A. ; Link, T. ; Hauke, J. ; Seither, F. ; Jackisch, C. ; Klare, P. ; Schmatloch, S. ; Hanusch, C. ; Huober, J. ; Stefek, A. ; Seiler, S. ; Schmitt, W.D. ; Uleer, C. ; Doering, G. ; Rhiem, K. ; Schneeweiss, A. ; Engels, K. ; Denkert, C. ; Schmutzler, R.K. ; Hahnen, E. ; Untch, M. ; Burchardi, N. ; Blohmer, J.-U. ; Loibl, S.

Annals of oncology, 2021-01, Vol.32 (1), p.49-57 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
4
Ribociclib plus fulvestrant for postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in the phase III randomized MONALEESA-3 trial: updated overall survival
Ribociclib plus fulvestrant for postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in the phase III randomized MONALEESA-3 trial: updated overall survival
Material Type:
Artigo 		Adicionar ao Meu Espaço

Ribociclib plus fulvestrant for postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in the phase III randomized MONALEESA-3 trial: updated overall survival

Slamon, D.J. ; Neven, P. ; Chia, S. ; Jerusalem, G. ; De Laurentiis, M. ; Im, S. ; Petrakova, K. ; Valeria Bianchi, G. ; Martín, M. ; Nusch, A. ; Sonke, G.S. ; De la Cruz-Merino, L. ; Beck, J.T. ; Ji, Y. ; Wang, C. ; Deore, U. ; Chakravartty, A. ; Zarate, J.P. ; Taran, T. ; Fasching, P.A.

Annals of oncology, 2021-08, Vol.32 (8), p.1015-1024 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
5
Veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in patients with BRCA1/2 locally recurrent/metastatic breast cancer: randomized phase II study
Veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in patients with BRCA1/2 locally recurrent/metastatic breast cancer: randomized phase II study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in patients with BRCA1/2 locally recurrent/metastatic breast cancer: randomized phase II study

Han, H.S. ; Diéras, V. ; Robson, M. ; Palácová, M. ; Marcom, P.K. ; Jager, A. ; Bondarenko, I. ; Citrin, D. ; Campone, M. ; Telli, M.L. ; Domchek, S.M. ; Friedlander, M. ; Kaufman, B. ; Garber, J.E. ; Shparyk, Y. ; Chmielowska, E. ; Jakobsen, E.H. ; Kaklamani, V. ; Gradishar, W. ; Ratajczak, C.K. ; Nickner, C. ; Qin, Q. ; Qian, J. ; Shepherd, S.P. ; Isakoff, S.J. ; Puhalla, S.

Annals of oncology, 2018-01, Vol.29 (1), p.154-161 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
6
Prognostic and predictive value of tumor-infiltrating lymphocytes in two phase III randomized adjuvant breast cancer trials
Prognostic and predictive value of tumor-infiltrating lymphocytes in two phase III randomized adjuvant breast cancer trials
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prognostic and predictive value of tumor-infiltrating lymphocytes in two phase III randomized adjuvant breast cancer trials

Dieci, M.V. ; Mathieu, M.C. ; Guarneri, V. ; Conte, P. ; Delaloge, S. ; Andre, F. ; Goubar, A.

Annals of oncology, 2015-08, Vol.26 (8), p.1698-1704 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
7
Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)
Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)

Schneeweiss, A. ; Puglisi, F. ; Peretz-Yablonski, T. ; Merot, J.-L. ; Miles, D. ; Coudert, Bruno ; Errihani, Hassan ; Dalenc, Florence ; Barrett, Sophie ; Beato, Carlos ; Hu, Xichun ; Perrin, Christophe ; Ettl, Johannes ; Li, Huiping ; Cariello, Anna ; Frassoldati, Antonio ; Wronski, Andrzej ; Menjón Beltrán, Salomón ; Cicin, Irfan ; Schmid, Peter ; Juarez, Alejandro ; Matos, Erika ; Uslu, Ruchan ; Wildiers, Hans ; Bourgeois, Hugues ; von Schumann, Raquel ; Wojtukiewicz, Marek ; Peron, Yann Izarzugaza ; Wheatley, Duncan ; De Boer, Richard ; Jerusalem, Guy ; Latini, Luciano ; Barnadas Molins, Agusti ; Martinez, Eduardo ; Baird, Richard ; McCarthy, Nicole ; Greil, Richard ; Juhasz-Boess, Ingolf ; de la Cruz, Luis Ruiz ; Del Val, Olga ; Azribi, Fathi ; Turner, Nicholas ; Andrade, Jurandyr ; Bernstein, Vanessa ; Rayson, Daniel ; Gennari, Alessandra ; El-Saghir, Nagi ; Kukulska, Monika ; Pelaez, Ignacio ; del Mar Gordon, Maria ; Varughese, Mohini ; Levitt, Nicola ; Singer, Christian ; Efremidou, Anna ; Evron, Ella ; Luigi, Cavanna ; Garcia, Andres ; Lopez Ceballos, Maria Helena ; García, María ; Arcediano, Alberto ; McAdam, Karen ; Humphreys, Alison ; de Grève, Jacques ; Joy, Anil ; Sehdev, Sandeep ; Kütner, Riina ; Laplaige, Philippe ; Christensen, Bernd ; Fountzilas, Georgios ; Fried, Georgeta ; Giacobino, Alice ; Bonetti, Andrea ; Van der Velden, Annette ; Vrijaldenhoven, Suzan ; Andres Conejero, Raquel ; Murias, Adolfo ; Saura, Salvador ; Poole, Christopher ; Woodward, Natasha ; Califaretti, Nadia ; Jiang, Jun ; Padrik, Peeter ; Saarni, Outi ; Genet, Dominique ; Catala, Stéphanie ; Facchini, Thomas ; Repp, Roland ; Schroeder, Willibald ; Kahan, Zsuzsanna ; Rosengarten, Ora ; Alabiso, Oscar ; Van de Wouw, Yes ; Sousa, Gabriela ; Jesús Florián Jerico, Marta Santisteban ; Torrego, Juan Carlos ; Rodriguez, Cesar ; Llorca, Cristina ; Galán, Antonio ; Rodríguez, Robinson ; Alonso, Isabel

Annals of oncology, 2019-05, Vol.30 (5), p.766-773 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
8
Long-term treatment efficacy in primary inflammatory breast cancer by hormonal receptor- and HER2-defined subtypes
Long-term treatment efficacy in primary inflammatory breast cancer by hormonal receptor- and HER2-defined subtypes
Material Type:
Artigo 		Adicionar ao Meu Espaço

Long-term treatment efficacy in primary inflammatory breast cancer by hormonal receptor- and HER2-defined subtypes

Masuda, H. ; Brewer, T.M. ; Liu, D.D. ; Iwamoto, T. ; Shen, Y. ; Hsu, L. ; Willey, J.S. ; Gonzalez-Angulo, A.M. ; Chavez-MacGregor, M. ; Fouad, T.M. ; Woodward, W.A. ; Reuben, J.M. ; Valero, V. ; Alvarez, R.H. ; Hortobagyi, G.N. ; Ueno, N.T.

Annals of oncology, 2014-02, Vol.25 (2), p.384-391 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
9
A decade of clinical development of PARP inhibitors in perspective
A decade of clinical development of PARP inhibitors in perspective
Material Type:
Artigo 		Adicionar ao Meu Espaço

A decade of clinical development of PARP inhibitors in perspective

Mateo, J. ; Lord, C.J. ; Serra, V. ; Tutt, A. ; Balmaña, J. ; Castroviejo-Bermejo, M. ; Cruz, C. ; Oaknin, A. ; Kaye, S.B. ; de Bono, J.S.

Annals of oncology, 2019-09, Vol.30 (9), p.1437-1447 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
10
Costs per event averted in the neoadjuvant and adjuvant settings of early triple-negative breast cancer
Costs per event averted in the neoadjuvant and adjuvant settings of early triple-negative breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Costs per event averted in the neoadjuvant and adjuvant settings of early triple-negative breast cancer

Olivier, T. ; Prasad, V.

Annals of oncology, 2023-08, Vol.34 (8), p.723-724 [Periódico revisado por pares]

England: Elsevier Ltd

Sem texto completo

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (1.502)

Data de Publicação 

De até
Refinar
  1. Antes de1996  (121)
  2. 1996Até2002  (254)
  3. 2003Até2009  (465)
  4. 2010Até2017  (538)
  5. Após 2017  (141)
  6. Mais opções open sub menu

Idioma 

  1. Japonês  (193)
  2. Russo  (12)
  3. Norueguês  (1)
  4. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.